Effect of Statins and PCSK9 Inhibition on Metabolic Dysfunction-Associated Steatotic Liver Disease. [PDF]
Theocharidou E, Gossios T.
europepmc +1 more source
Rationale and Design of the EPISODE Trial: A Randomized Controlled Trial on the Effect of PCSK9 Inhibitors in Calcific Aortic Valve Stenosis. [PDF]
Zheng Y +6 more
europepmc +1 more source
Association Between HNP1-3 and Atherosclerotic Plaque Burden in Subclinical Atherosclerosis and the Mediating Effect of PCSK9. [PDF]
Yurtseven E +10 more
europepmc +1 more source
Genetic Pathogenesis of Abdominal Aortic Aneurysm and the Role of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9). [PDF]
Choi JY, Gwon JG.
europepmc +1 more source
Efficacy and safety of PCSK9 inhibitors in patients with chronic kidney disease. [PDF]
Tang H +6 more
europepmc +1 more source
Apolipoproteins in Chronic Kidney Disease and Kidney Transplant: A Long Unfinished Story. [PDF]
Secondulfo C +14 more
europepmc +1 more source
<i><b>PCSK9</b></i> <b>genetic variants, carotid atherosclerosis and vascular remodelling</b>. [PDF]
Coggi D +24 more
europepmc +1 more source
Association between proprotein convertase subtilisin/kexin type 9 targeted therapies and the risk of arrhythmias: a meta-analysis of randomized controlled trials. [PDF]
Jaiswal V +12 more
europepmc +1 more source

